These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 3691150)
21. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function. Jaggi M; Nakagawa Y; Zipperle L; Hess B Urol Res; 2007 Apr; 35(2):55-62. PubMed ID: 17345077 [TBL] [Abstract][Full Text] [Related]
22. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F; Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027 [TBL] [Abstract][Full Text] [Related]
23. Low urine citrate excretion as main risk factor for recurrent calcium oxalate nephrolithiasis in males. Cupisti A; Morelli E; Lupetti S; Meola M; Barsotti G Nephron; 1992; 61(1):73-6. PubMed ID: 1528345 [TBL] [Abstract][Full Text] [Related]
24. Calcium oxalate nephrolithiasis: an easy way to detect an imbalance between promoting and inhibiting factors. Baggio B; Gambaro G; Oliva O; Favaro S; Borsatti A Clin Chim Acta; 1982 Sep; 124(2):149-55. PubMed ID: 6216029 [TBL] [Abstract][Full Text] [Related]
25. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate. Pak CY; Peterson R Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975 [TBL] [Abstract][Full Text] [Related]
26. Effect of calcium citrate supplementation on urinary calcium oxalate saturation in female stone formers: implications for prevention of osteoporosis. Levine BS; Rodman JS; Wienerman S; Bockman RS; Lane JM; Chapman DS Am J Clin Nutr; 1994 Oct; 60(4):592-6. PubMed ID: 8092096 [TBL] [Abstract][Full Text] [Related]
28. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress. Asokan D; Kalaiselvi P; Varalakshmi P Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748 [TBL] [Abstract][Full Text] [Related]
29. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers. Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653 [TBL] [Abstract][Full Text] [Related]
30. Long-term treatment of calcium nephrolithiasis with potassium citrate. Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044 [TBL] [Abstract][Full Text] [Related]
31. On the relation between citrate and calcium in normal and stone-former subjects. Conte A; Roca P; Gianotti M; Grases F Int Urol Nephrol; 1989; 21(4):369-73. PubMed ID: 2613466 [TBL] [Abstract][Full Text] [Related]
32. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi]. Boruczkowska A Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956 [TBL] [Abstract][Full Text] [Related]
33. The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro. Ryall RL; Harnett RM; Marshall VR Clin Chim Acta; 1981 May; 112(3):349-56. PubMed ID: 6263523 [TBL] [Abstract][Full Text] [Related]
34. Physicochemical considerations in the development and prevention of calcium oxalate urolithiasis. Kok DJ; Papapoulos SE Bone Miner; 1993 Jan; 20(1):1-15. PubMed ID: 8453319 [TBL] [Abstract][Full Text] [Related]
35. [Risk indicators of urinary calculus formation: value of oxalate and citrate excretion in comparison with the oxalate tolerance value]. Hannak D; Burczyk U; Bartelt U; Kattermann R Urologe A; 1989 Jan; 28(1):20-4. PubMed ID: 2922896 [TBL] [Abstract][Full Text] [Related]
36. [Alkalinizing treatment as a preventative of recurrent calcium oxalate lithiasis]. Cifuentes Delatte L Arch Esp Urol; 1991 Oct; 44(8):903-10. PubMed ID: 1796852 [TBL] [Abstract][Full Text] [Related]
37. Some acid-base balance-dependent urinary parameters and calcium-binding anions in stone formers. Vogel E; Leskovar P; Schütz W Eur Urol; 1984; 10(4):254-9. PubMed ID: 6479200 [TBL] [Abstract][Full Text] [Related]
38. A critical evaluation of the urinary inhibiting activity in idiopathic calcium oxalate nephrolithiasis. Gambaro G; Cicerello E; Marzaro G; Marchini F; Piccoli A; Paleari C; Baggio B Urol Int; 1986; 41(6):418-21. PubMed ID: 3824697 [TBL] [Abstract][Full Text] [Related]
39. Urinary phytate in calcium oxalate stone formers and healthy people--dietary effects on phytate excretion. Grases F; March JG; Prieto RM; Simonet BM; Costa-Bauzá A; García-Raja A; Conte A Scand J Urol Nephrol; 2000 Jun; 34(3):162-4. PubMed ID: 10961468 [TBL] [Abstract][Full Text] [Related]
40. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones? Laube N; Jansen B; Hesse A Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]